Volume 24, Number 2 - October 2021

Insujet (version 5) needle free injection device

European Pharma Group

The Netherlands,

announces

 Meditrend International Pty Ltd 

 as the new Australian Distributor

 for the InsuJet (Version 5) Needle-Free Injection device and Consumables, effective July 2021.

The InsuJet is developed for people with diabetes who require insulin therapy and is suitable for all types of insulin.

 The system is especially suitable for patients who have needle-phobia, but it can be used by anyone who wishes to avoid using needles.

 The device uses liquid jet injection technology, which allows a fine stream of insulin to penetrate the skin.

This results in a complete injection, a safe and effective alternative to conventional needle-injections.

Acknowledgements

Discussion

There are currently no comments.

Your email address will not be published. Required fields are marked *

Other Articles in this Edition